(2S,4R)-1-((S)-3,3-dimethyl-2-(2-oxopyrrolidin-1-yl)butanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide

ID: ALA4229276

PubChem CID: 145988632

Max Phase: Preclinical

Molecular Formula: C26H34N4O4S

Molecular Weight: 498.65

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](N2CCCC2=O)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C26H34N4O4S/c1-16-22(35-15-28-16)18-9-7-17(8-10-18)13-27-24(33)20-12-19(31)14-30(20)25(34)23(26(2,3)4)29-11-5-6-21(29)32/h7-10,15,19-20,23,31H,5-6,11-14H2,1-4H3,(H,27,33)/t19-,20+,23-/m1/s1

Standard InChI Key:  UTQIQISFAOFPCJ-ZRCGQRJVSA-N

Molfile:  

     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   33.5460   -3.3001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2627   -2.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5508   -2.4752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2627   -4.5376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9772   -4.1251    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.5482   -4.1251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2627   -5.3625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.7307   -4.4555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2827   -3.8424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8702   -3.1278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0633   -3.2996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9045   -5.2620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2930   -5.8158    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.6898   -5.5147    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.8635   -6.3213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6489   -6.5740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8208   -7.3788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6053   -7.6317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2178   -7.0776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0406   -6.2676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2563   -6.0185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0035   -7.3294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2607   -8.1094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.0857   -8.1061    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.3374   -7.3203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.6680   -6.8383    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   39.7786   -8.7789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8338   -4.5376    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.2057   -2.3742    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.8338   -2.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0803   -4.2021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5283   -4.8152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9408   -5.5297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7478   -5.3580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9088   -3.3952    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  1  3  1  0
  4  5  1  0
  4  6  1  0
  4  7  2  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  5  1  0
  8 12  1  1
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 19 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 22  1  0
 23 27  1  0
  6  1  1  1
  6 28  1  0
 10 29  1  6
  1 30  1  0
 28 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 28  1  0
 31 35  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4229276

    ---

Associated Targets(Human)

VHL Tchem Von Hippel-Lindau disease tumor suppressor/Elongin B/Elongin C (158 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 498.65Molecular Weight (Monoisotopic): 498.2301AlogP: 2.73#Rotatable Bonds: 6
Polar Surface Area: 102.84Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.65CX LogP: 1.12CX LogD: 1.12
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.64Np Likeness Score: -0.75

References

1. Soares P, Gadd MS, Frost J, Galdeano C, Ellis L, Epemolu O, Rocha S, Read KD, Ciulli A..  (2018)  Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298).,  61  (2): [PMID:28853884] [10.1021/acs.jmedchem.7b00675]

Source